Condition
Pseudoarthrosis of Bone
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05183542Not ApplicableRecruitingPrimary
SPECT/CT Bone Scan Quantification Surgery
NCT06103396Phase 1UnknownPrimary
Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)
NCT05423561Not ApplicableCompletedPrimary
Corticalisation After Femoral Nail Dynamization in Hypertrophic Non-unions
NCT05049915Not ApplicableUnknownPrimary
Evaluation of the Clinical Effectiveness of Bioactive Glass (S53P4) in the Treatment of Tibia and Femur Non-unions
NCT03620305CompletedPrimary
Septic Pseudarthrosis Of Long Bone : Experience In A Regional Reference Center
Showing all 5 trials